Health Condition 1: H356- Retinal hemorrhage
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
Dr Swarna Paliwal
Eligibility
Inclusion criteria
Inclusion criteria: patient confirmed with type 2 diabetes mellitus
Exclusion criteria
Exclusion criteria: 1. Patient having retinopathy other than DR 2. Use of medications that could influence serum ceruloplasmin levels or lipid profiles, such as corticosteroids or lipid-lowering agents. 3. Patient with coexisting diabetic nephropathy 4. Patients with history of recent surgery/trauma/infection/inflammation 5.Patient with severe hepatic/renal diseases 6.Pregnant or breastfeeding women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To measure the serum ceruloplasmin levels and TG/HDL-C ratio in type 2 Diabetes Mellitus (DM) patients without DR, type 2 DM with DR and age- and sex-matched non-diabetic controlsTimepoint: 1 YEAR | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.To analyse the differences in serum ceruloplasmin levels & TG/HDL-C ratio among non-diabetic controls, diabetic patients without DR, diabetic patients with DR 2.To perform receiver operating characteristic (ROC) curve analysis for evaluating the discriminative power of serum ceruloplasmin levels & TG/HDL-C ratio in non-diabetic controls, diabetic patients without DR & diabetic patients with DR. Timepoint: 1 YEAR | — |
Countries
India
Contacts
Public ContactDr Jitendra Ahuja
RUHS college of medical sciences,jaipur
Outcome results
None listed